---
title: Buy Edarbi (Azilsartan Medoxomil) 40mg Pills Online
description: Edarbi (Azilsartan) 40mg Pills is a trusted treatment for high blood pressure. Order from our secure online pharmacy for verified quality and shipping.
type: product
language: en 
url: https://medsforsale.net/buy-edarbi-online-en
availability: in_stock
price_min: 59.99
price_max: 269.99
currency: USD
offers:
  - name: 40mg x 30 pills
    price: 59.99
  - name: 40mg x 60 pills
    price: 107.99
  - name: 40mg x 90 pills
    price: 152.99
  - name: 40mg x 120 pills
    price: 191.99
  - name: 40mg x 180 pills
    price: 269.99
---

# Buy Edarbi (Azilsartan Medoxomil) 40mg Pills Online

Edarbi, containing Azilsartan medoxomil, is a modern angiotensin II receptor blocker (ARB) developed by Takeda Pharmaceuticals. It is used to treat hypertension (high blood pressure), helping to lower the risk of stroke and heart attack by relaxing blood vessels for improved blood flow. It is ideal for adults seeking an effective way to manage their cardiovascular health. Edarbi is available through our trusted online platform in 40mg pills.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **40mg** | 30 pills | **$59.99** | $2.00 | In Stock |
| **40mg** | 60 pills | **$107.99** | $1.80 | In Stock |
| **40mg** | 90 pills | **$152.99** | $1.70 | In Stock |
| **40mg** | 120 pills | **$191.99** | $1.60 | In Stock |
| **40mg** | 180 pills | **$269.99** | $1.50 | In Stock |


[Buy Now](https://medsforsale.net/buy-edarbi-online-en)

## Introduction 

Edarbi is a prescription medication whose active ingredient is azilsartan medoxil, an angiotensin II receptor blocker (ARB). It is supplied as a 40 mg oral tablet and is indicated primarily for the treatment of hypertension in adults. The drug belongs to the class of renin-angiotensin-aldosterone system (RAAS) inhibitors, which lower blood pressure by blocking the effects of angiotensin II. In addition to its approved use for high blood pressure, azilsartan medoxil has been investigated in clinical research for several off-label applications, such as heart failure with preserved ejection fraction and proteinuric kidney disease.

---

## What is Edarbi? 

Edarbi is the generic version of well-known medications containing the active compound azilsartan medoxil. [our online pharmacy](https://medsforsale.net/buy-edarbi-online-en) provides this generic alternative as a cost-effective treatment option. Azilsartan medoxil is marketed under brand names such as **Edarbi** and **Azilsartan** in various international markets. The product is manufactured by Takeda Pharmaceutical Company and is supplied as a hard-film coated tablet containing 40 mg of azilsartan medoxil.

---

## How Edarbi Works 

Azilsartan medoxil is a pro-drug that is rapidly hydrolyzed in the gastrointestinal tract to the active molecule azilsartan. Azilsartan selectively binds to the angiotensin II type 1 (AT₁) receptor, preventing angiotensin II from exerting its vasoconstrictive and aldosterone-secreting actions. The blockade of AT₁ receptors results in: 

- **Vasodilation:** Reduced peripheral vascular resistance lowers systolic and diastolic blood pressure. 
- **Decreased sodium-water retention:** Inhibition of aldosterone release leads to modest natriuresis, contributing to blood-pressure reduction. 

Azilsartan has a high affinity for the AT₁ receptor and a long half-life of approximately 11 hours, allowing once-daily dosing. Steady-state plasma concentrations are typically achieved after 3-4 days of consistent therapy.

---

## Conditions Treated with Edarbi 

- **Essential (primary) hypertension:** Clinical trials have demonstrated that azilsartan medoxil effectively reduces systolic blood pressure by an average of 12-14 mm Hg and diastolic pressure by 8-10 mm Hg when administered at 40 mg daily. The medication is recommended as a first-line or add-on therapy for adult patients whose blood pressure is not adequately controlled with lifestyle measures alone. 

The efficacy in hypertension results from the drug’s potent, long-lasting AT₁ blockade, which produces consistent reductions in vascular tone and volume overload.

---

## Off-Label and Investigational Uses of Edarbi 

- **Heart failure with preserved ejection fraction (HFpEF):** Small randomized studies have suggested that azilsartan may improve diastolic function and lower natriuretic peptide levels. However, regulatory agencies have not approved this indication, and larger trials are needed. 
- **Proteinuric chronic kidney disease:** Early-phase research indicates that ARBs, including azilsartan, can reduce albuminuria in patients with diabetic or non-diabetic nephropathy. The effect appears comparable to other ARBs, but long-term renal outcomes remain unconfirmed. 
- **Metabolic syndrome:** Observational data have linked ARB therapy to modest improvements in insulin sensitivity. While azilsartan has not been formally evaluated for metabolic control, clinicians sometimes consider it when hypertension coexists with insulin resistance. 

All off-label uses should be undertaken only under direct supervision of a qualified healthcare provider, as safety and efficacy have not been formally evaluated by the FDA or EMA for these conditions.

---

## Is Edarbi the Right Medication for You? 

Edarbi is most appropriate for adult patients with diagnosed essential hypertension who require pharmacologic blood-pressure control. It is especially useful when: 

- Monotherapy with an ACE inhibitor, calcium-channel blocker, or thiazide diuretic has not achieved target blood pressure. 
- The patient prefers a once-daily regimen due to a predictable pharmacokinetic profile. 

**Contraindications** include: 

- Known hypersensitivity to azilsartan, any ARB, or any component of the tablet. 
- Severe hepatic impairment (Child-Pugh C), as drug metabolism may be unpredictable. 
- Pregnancy or lactation, because blockade of the renin-angiotensin system can harm the fetus. 

Patients with bilateral renal artery stenosis, hyperkalemia (>5.5 mmol/L), or those concurrently using aliskiren (a direct renin inhibitor) should avoid Edarbi unless closely monitored.

---

## Risks, Side Effects, and Interactions 

### Common 

- **Dizziness or light-headedness:** Often occurs when standing quickly due to lowered blood pressure. 
- **Headache:** Typically mild and transient during the first weeks of therapy. 
- **Fatigue:** May be related to hemodynamic changes. 

### Rare 

- **Elevated serum potassium (hyperkalemia):** More likely in patients with renal impairment or those taking potassium-sparing diuretics. 
- **Increased serum creatinine:** Indicates reduced glomerular filtration; monitor renal function after initiation. 

### Serious 

- **Angio-edema:** Swelling of the face, lips, tongue, or airway; requires immediate medical attention. 
- **Severe hypotension:** Particularly in volume-depleted patients or those on concurrent antihypertensives. 
- **Renal failure:** Acute kidney injury may develop in patients with renal artery stenosis or severe dehydration.

#### Drug-Drug Interactions 

- **Potassium-containing supplements, potassium-sparing diuretics (e.g., spironolactone), and salt substitutes** - increase the risk of hyperkalemia. 
- **Non-steroidal anti-inflammatory drugs (NSAIDs)** - may blunt antihypertensive effect and worsen renal function. 
- **Lithium** - concurrent use can raise lithium levels, leading to toxicity. 
- **Dual RAAS blockade (e.g., ACE inhibitor + ARB)** - amplifies risk of hypotension, hyperkalemia, and renal dysfunction; generally not recommended. 

#### Drug-Food Interactions 

- No specific dietary restrictions, but a **low-salt diet** enhances blood-pressure control. 
- Grapefruit juice does not affect azilsartan metabolism and is therefore permissible.

---

## Use: Dosing, Missed Dose, Overdose 

- **Standard dosing:** For most adults, the initial dose is 40 mg taken once daily with or without food. Dose adjustments are rarely required because 40 mg provides near-maximum AT₁ blockade. 
- **Missed dose:** If a dose is forgotten, take it as soon as remembered unless it is within 12 hours of the next scheduled dose. In that case, skip the missed tablet and resume the regular dosing schedule. Do not double-dose. 
- **Overdose:** Symptoms may include profound hypotension, dizziness, and renal impairment. Seek emergency medical care immediately. Treatment is mainly supportive-intravenous fluids and vasopressors may be required to maintain blood pressure. 

**Practical precautions:** 

- Avoid abrupt discontinuation; tapering is not usually necessary, but patients should be monitored for rebound hypertension. 
- Alcohol does not directly interact with azilsartan, but excessive intake can exacerbate hypotension. 
- Caution when operating machinery or driving until the individual knows how the medication affects them.

---

## FAQ 

- **Can I take Edarbi with a high-protein diet?** 
 Yes. Azilsartan’s absorption is not significantly affected by dietary protein, so a high-protein diet does not require dose adjustment. 

- **Will Edarbi cause weight gain?** 
 Weight change is not a recognized side effect of azilsartan. Any observed weight fluctuation is more likely related to fluid balance changes from concomitant diuretics. 

- **Is it safe to travel internationally with Edarbi tablets?** 
 Edarbi tablets are generally accepted for personal use in most countries, provided they remain in the original packaging with a copy of the prescription. However, travelers should verify local import regulations before departure. 

- **How should I store Edarbi in a hot climate?** 
 Store the tablets at 20-25 °C (68-77 °F) in a dry place. If ambient temperatures exceed 30 °C (86 °F) for prolonged periods, keep the medication in a climate-controlled environment or a sealed container with a cooling pack. 

- **What inactive ingredients are present in the 40 mg tablet?** 
 The tablet contains lactose monohydrate, microcrystalline cellulose, magnesium stearate, and a film coating of hypromellose. Patients with severe lactose intolerance should discuss alternatives with their clinician. 

- **Does Edarbi interfere with urine drug testing?** 
 Azilsartan is not a prohibited substance and does not produce a false-positive result on standard immunoassay drug screens. 

- **Can Edarbi be taken during Ramadan fasting?** 
 Because the medication can be taken with or without food, patients may choose a dosing time that aligns with the pre-dawn or sunset meals, but they should maintain consistent daily timing to preserve blood-pressure control. 

- **Is it necessary to monitor blood pressure at home while on Edarbi?** 
 Home blood-pressure monitoring is encouraged, especially during the first few weeks of therapy, to confirm that target levels are achieved and to detect any episodes of hypotension. 

- **Are there differences between generic azilsartan medoxil and the brand Edarbi?** 
 The generic and brand formulations contain the same active ingredient, dosage strength, and exhibit bioequivalence as required by regulatory agencies. Inactive excipients may vary slightly, but clinical efficacy and safety are comparable. 

- **What should I do if I experience persistent cough while using Edarbi?** 
 A dry cough is more typical of ACE inhibitors than ARBs. If coughing occurs, evaluate other possible causes and discuss with a healthcare professional; switching to an ARB like Edarbi is often considered when ACE-inhibitor-induced cough is problematic. 

---

## Glossary 

**Angiotensin II Receptor Blocker (ARB)** 
: A class of medications that inhibit the AT₁ receptor, preventing angiotensin II-mediated vasoconstriction and aldosterone release, thereby lowering blood pressure. 

**Hyperkalemia** 
: An abnormally high concentration of potassium in the blood, which can cause cardiac arrhythmias if severe. 

**Bioequivalence** 
: A regulatory standard indicating that two drug products (e.g., generic and brand) deliver the same amount of active ingredient into the bloodstream at the same rate. 

---

## Buying Edarbi from [our online pharmacy](https://medsforsale.net/buy-edarbi-online-en) 

Edarbi can be purchased from **[our online pharmacy](https://medsforsale.net/buy-edarbi-online-en)**, which offers a streamlined, discreet service for patients seeking reliable access to affordable generic azilsartan medoxil. By partnering with licensed overseas suppliers, we obtain the medication at near-manufacturer pricing, allowing us to pass substantial savings on to you. Every batch is sourced from vetted, GMP-certified manufacturers, ensuring consistent potency and purity. 

Delivery is handled with privacy in mind: packages are shipped in unmarked envelopes, and you can choose between express (approximately 7 days) or regular airmail (about 3 weeks) based on your needs. Our pharmacy broker model enables us to provide international medications to patients in regions where local availability may be limited or where insurance coverage does not include the generic version. The process is secure, confidential, and designed to reduce the financial and logistical barriers that often accompany chronic-disease treatment. 

---

## Disclaimer 

The information provided about **Edarbi** is intended for general educational purposes only and does not replace professional medical consultation. All treatment decisions, including those concerning off-label applications, should be made under the supervision of a qualified healthcare provider. Readers are assumed to be responsible adults capable of making informed health decisions. [our online pharmacy](https://medsforsale.net/buy-edarbi-online-en) offers access to **Edarbi** for individuals who may experience limited availability through conventional pharmacies, prescription-based insurance plans, or who are seeking cost-effective generic alternatives. Always consult your physician before initiating, altering, or discontinuing any medication.